BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$9.06
+1.51%
Mkt Cap $1.72B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$17.00
Range $9.00 – $25.00
Implied Upside
+87.7%
Consensus $17.00 vs current $9.06
NASDAQ·Healthcare·Biotechnology
$9.06
+1.51%
Mkt Cap $1.72B
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$17.00
Range $9.00 – $25.00
+87.7%
Consensus $17.00 vs current $9.06